Elizabeth L Prado1, Souheila Abbeddou2, Elizabeth Yakes Jimenez3, Jérôme W Somé4, Zinewendé P Ouédraogo5, Steve A Vosti6, Kathryn G Dewey2, Kenneth H Brown7, Sonja Y Hess2, Jean-Bosco Ouédraogo5. 1. Departments of Nutrition and elprado@ucdavis.edu. 2. Departments of Nutrition and. 3. Departments of Individual, Family, and Community Education and Family and Community Medicine, University of New Mexico, Albuquerque, NM; 4. Departments of Nutrition and Institut de Recherche en Sciences de la Santé/Direction Régionale de l'Ouest (Health Sciences Research Institute/Western Regional Directorate), Bobo-Dioulasso, Burkina Faso; and. 5. Institut de Recherche en Sciences de la Santé/Direction Régionale de l'Ouest (Health Sciences Research Institute/Western Regional Directorate), Bobo-Dioulasso, Burkina Faso; and. 6. Agricultural and Resource Economics, University of California Davis, Davis, CA; 7. Departments of Nutrition and Bill & Melinda Gates Foundation, Seattle, WA.
Abstract
BACKGROUND: Adequate nutrition is necessary for the rapid brain development that occurs during infancy. OBJECTIVES: We tested the hypothesis that the provision of small-quantity, lipid-based nutrient supplements (SQ-LNSs) plus malaria and diarrhea treatment positively affects infant development. We also tested the effect of various doses of zinc provided in SQ-LNSs or in a tablet. METHODS: In a partially masked, cluster-randomized controlled trial, communities in rural Burkina Faso were stratified by selected characteristics and then randomly assigned within strata to the intervention (IC; 25 communities, 2435 children) or the nonintervention (NIC; 9 communities, 785 children) cohorts. IC children were randomly assigned to 4 groups. As secondary outcomes, a subsample of 3 of these 4 groups (n = 747) and of the NIC (n = 376) were assessed for motor, language, and personal-social development at age 18 mo by using the Developmental Milestones Checklist II. The 3 IC groups received 20 g SQ-LNSs/d containing 0 or 10 mg added zinc with a placebo tablet or 20 g SQ-LNSs/d containing 0 mg added zinc with a tablet containing 5 mg Zn. All IC groups received treatment of malaria and diarrhea from age 9 to 18 mo. Data collectors and participants were aware of allocation to the IC or NIC but did not know the particular IC subgroup. RESULTS: Children in the IC scored 0.34 (95% CI: 0.21, 0.46), 0.30 (95% CI: 0.15, 0.44), and 0.32 (95% CI: 0.16, 0.48) SDs higher in motor, language, and personal-social development, respectively, than did children in the NIC (All P < 0.001). Children who received different amounts of zinc did not differ significantly in any of the scores. No effect on caregiver-child interaction was found. CONCLUSION: In rural Burkina Faso, the provision of SQ-LNSs to infants from age 9 to 18 mo, regardless of added zinc content, plus malaria and diarrhea treatment positively affected motor, language, and personal-social development at age 18 mo. This trial was registered at clinicaltrials.gov as NCT00944281.
RCT Entities:
BACKGROUND: Adequate nutrition is necessary for the rapid brain development that occurs during infancy. OBJECTIVES: We tested the hypothesis that the provision of small-quantity, lipid-based nutrient supplements (SQ-LNSs) plus malaria and diarrhea treatment positively affects infant development. We also tested the effect of various doses of zinc provided in SQ-LNSs or in a tablet. METHODS: In a partially masked, cluster-randomized controlled trial, communities in rural Burkina Faso were stratified by selected characteristics and then randomly assigned within strata to the intervention (IC; 25 communities, 2435 children) or the nonintervention (NIC; 9 communities, 785 children) cohorts. IC children were randomly assigned to 4 groups. As secondary outcomes, a subsample of 3 of these 4 groups (n = 747) and of the NIC (n = 376) were assessed for motor, language, and personal-social development at age 18 mo by using the Developmental Milestones Checklist II. The 3 IC groups received 20 g SQ-LNSs/d containing 0 or 10 mg added zinc with a placebo tablet or 20 g SQ-LNSs/d containing 0 mg added zinc with a tablet containing 5 mg Zn. All IC groups received treatment of malaria and diarrhea from age 9 to 18 mo. Data collectors and participants were aware of allocation to the IC or NIC but did not know the particular IC subgroup. RESULTS:Children in the IC scored 0.34 (95% CI: 0.21, 0.46), 0.30 (95% CI: 0.15, 0.44), and 0.32 (95% CI: 0.16, 0.48) SDs higher in motor, language, and personal-social development, respectively, than did children in the NIC (All P < 0.001). Children who received different amounts of zinc did not differ significantly in any of the scores. No effect on caregiver-child interaction was found. CONCLUSION: In rural Burkina Faso, the provision of SQ-LNSs to infants from age 9 to 18 mo, regardless of added zinc content, plus malaria and diarrhea treatment positively affected motor, language, and personal-social development at age 18 mo. This trial was registered at clinicaltrials.gov as NCT00944281.
Authors: Elizabeth L Prado; John Phuka; Kenneth Maleta; Per Ashorn; Ulla Ashorn; Steve A Vosti; Kathryn G Dewey Journal: Matern Child Health J Date: 2016-10
Authors: Jai K Das; Rehana A Salam; Yousaf Bashir Hadi; Sana Sadiq Sheikh; Afsah Z Bhutta; Zita Weise Prinzo; Zulfiqar A Bhutta Journal: Cochrane Database Syst Rev Date: 2019-05-02
Authors: Elizabeth L Prado; Souheila Abbeddou; Elizabeth Yakes Jimenez; Jérôme W Somé; Kathryn G Dewey; Kenneth H Brown; Sonja Y Hess Journal: Matern Child Nutr Date: 2016-05-04 Impact factor: 3.092
Authors: O Yaw Addo; Katie Tripp; Simeon Nanama; Bope Albert; Fanny Sandalinas; Ambroise Nanema; Maria Elena Jefferds; Heather B Clayton; Ralph D Whitehead; Aashima Garg; Roland Kupka; Lindsey M Locks Journal: J Pediatr Date: 2020-02-28 Impact factor: 6.314
Authors: Elizabeth L Prado; Souheila Abbeddou; Seth Adu-Afarwuah; Mary Arimond; Per Ashorn; Ulla Ashorn; Jaden Bendabenda; Kenneth H Brown; Sonja Y Hess; Emma Kortekangas; Anna Lartey; Kenneth Maleta; Brietta M Oaks; Eugenia Ocansey; Harriet Okronipa; Jean Bosco Ouédraogo; Anna Pulakka; Jérôme W Somé; Christine P Stewart; Robert C Stewart; Stephen A Vosti; Elizabeth Yakes Jimenez; Kathryn G Dewey Journal: J Child Psychol Psychiatry Date: 2017-05-23 Impact factor: 8.982
Authors: Christine P Stewart; Patricia Kariger; Lia Fernald; Amy J Pickering; Charles D Arnold; Benjamin F Arnold; Alan E Hubbard; Holly N Dentz; Audrie Lin; Theodora J Meerkerk; Erin Milner; Jenna Swarthout; John M Colford; Clair Null Journal: Lancet Child Adolesc Health Date: 2018-04
Authors: Boris Martinez; Sayra Cardona; Patricia Rodas; Meri Lubina; Ana Gonzalez; Meghan Farley Webb; Maria Del Pilar Grazioso; Peter Rohloff Journal: BMJ Paediatr Open Date: 2018-10-03